Terns Pharmaceuticals, Inc. — Director's Dealing 2023

Nov 18, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Terns Pharmaceuticals, Inc. (TERN)
CIK: 0001831363
Period of Report: 2023-11-15

Reporting Person: Quigley Jill M. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-11-15	Common Stock	A	15000.00	$0.00	Acquired	15000.00	Direct

Footnotes

F1: Each share is represented by a Restricted Stock Unit ("RSU"). 100% of the RSUs will vest on August 1, 2024 (the "Vesting Date"), subject to the Reporting Person's continued service to the Issuer through the Vesting Date.